Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
neoplas tools is a German plasma medicine and medical device company spun out of the Leibniz Institute for Plasma Science and Technology (INP) in Greifswald in 2009. The company initially manufactured plasma sources for technical applications and later focused on plasma medicine, commercializing the kINPen MED cold atmospheric-pressure plasma jet for wound treatment and pathogen-induced skin disorders. Published sources describe neoplas tools as the former name of neoplas med, which introduced kINPen MED to the European market as a CE-marked Class IIa medical device. Its technology uses argon-based cold plasma for contactless treatment intended to reduce bioburden and support tissue regeneration in difficult-to-heal wounds. In practice, the entity appears to have transitioned from an industrial/plasma-tools business into a healthcare-focused medtech business now operating under the neoplas med name.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on neoplas tools.